Ahmed S.A. Mady

Biochemistry, Genetics and Molecular Biology · University of Michigan

Mid career · publishing since 2010

Cell death mechanisms and regulation Cancer Mechanisms and Therapy Cancer-related Molecular Pathways Ubiquitin and proteasome pathways Click Chemistry and Applications

Publications

Citations

768

Est. group size

Recurring co-author estimate

Active years

Publishing since 2010

In context

Among 1,692 mid career Biochemistry, Genetics and Molecular Biology PIs within our index

Citations: 768cohort median 809

Publications / year (recent): 1.8cohort median 3.2

Typically publishes in teams of ~14 · 10% small-team papers (≤3 authors) · across 7 venues

Publication cadence

Publications per year over the last 10 years — averaging 1.8/year recently

Collaborators per year

Distinct co-authors at University of Michigan each year — a rough indication of whether the group around this researcher has been growing or contracting. An estimate from co-authorship, not a roster: collaborators are not necessarily lab members, and recent years can be under-counted while indexing catches up.

Recent publications

DGAT1 mediates sex-specific CD8+ T cell antitumour responses
Nature Metabolism · 2026
Chemoproteomics discovery of a CNS-penetrant covalent inhibitor of PIKfyve
bioRxiv (Cold Spring Harbor Laboratory) · 2026
A small-molecule inhibitor of BCL10-MALT1 interaction abrogates progression of diffuse large B cell lymphoma
Journal of Clinical Investigation · 2025
Abstract 2154: PARP7 inhibitor RBN-2397 increases tumoral IFN signaling leading to various tumor cell intrinsic effects and tumor regressions in mouse models
Cancer Research · 2022
PARP7 negatively regulates the type I interferon response in cancer cells and its inhibition triggers antitumor immunity
Cancer Cell · 2021
Abstract 3404: Inhibition of BCL10-MALT1 interaction to treat diffuse large B-cell lymphoma
Cancer Research · 2020
The WD40 domain of FBXW7 is a poly(ADP-ribose)-binding domain that mediates the early DNA damage response
Nucleic Acids Research · 2019
Abstract 1970: Novel Mcl-1 inhibitor effectively restores in vivo regorafenib sensitivity in resistant colorectal cancer
Cancer Research · 2018
Abstract 1173: A novel selective Mcl-1 inhibitor exhibits in vitro and in vivo efficacy in melanoma
Cancer Research · 2017
Development and Characterization of Novel Mcl-1 Inhibitors for Treatment of Cancer.
Deep Blue (University of Michigan) · 2016

Publishes in

Cancer Research×4
Journal of Clinical Investigation×2
bioRxiv (Cold Spring Harbor Laboratory)×2
Cancer Cell×1
Nucleic Acids Research×1

Similar researchers

By research-topic overlap

Jennifer Fox
Biochemistry, Genetics and Molecular Biology · University of Michigan
Karson J. Kump
Biochemistry, Genetics and Molecular Biology · University of Michigan
Zaneta Nikolovska‐Coleska
Biochemistry, Genetics and Molecular Biology · University of Michigan
Anita C. Bellail
Biochemistry, Genetics and Molecular Biology · Indiana University
Colin S. Duckett
Biochemistry, Genetics and Molecular Biology · University of Michigan

This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.

Last updated Jul 25, 2026.

Claim or correct this profile